Sort   by:  
 Page size 
UnknownL25 functions as a conserved ribosomal docking site shared by nascent chain-associated complex and signal-recognition particle.
Not available
S-EPMC1369221 | biostudies-literature
UnknownSuppressive activity of Vδ2+ γδ T cells on αβ T cells is licensed by TCR signaling and correlates with signal strength.
Not available
S-EPMC7113223 | biostudies-literature
TranscriptomicsAnalysis of P-body (Dcp1) and Stress Granule (Pbp1) RNA content
Non-membrane-bound compartments such as mRNA processing bodies (PBs) and stress granules (SGs) play important roles in the regulation of gene expression following environmental stresses. Here we perform RIP-seq to determine the RNA interactors of Dcp1 (PB marker) and Pbp1 (SG marker) before and afte...
ORGANISM(S): Saccharomyces cerevisiae 
2021-09-30 | E-MTAB-9096 | biostudies-arrayexpress
UnknownIntratibial injection of human multiple myeloma cells in NOD/SCID IL-2Rγ(null) mice mimics human myeloma and serves as a valuable tool for the development of anticancer strategies.
Not available
S-EPMC3819303 | biostudies-literature
UnknownSafety of unconventional antibody-drug conjugate L-DOS47 in a phase I/II monotherapy study targeting advanced NSCLC.
Not available
S-EPMC12375440 | biostudies-literature
UnknownPatient derived renal cell carcinoma xenografts exhibit distinct sensitivity patterns in response to antiangiogenic therapy and constitute a suitable tool for biomarker development.
Not available
S-EPMC6089561 | biostudies-literature
UnknownA fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties.
Not available
S-EPMC4169037 | biostudies-literature
UnknownMulticentre Randomised trial of Acute Stroke treatment in the Ambulance with a nitroglycerin Patch (MR ASAP): study protocol for a randomised controlled trial.
Not available
S-EPMC6595565 | biostudies-literature
ProteomicsLC-MS/MS analyses of human PDAC cell lines after treatment with a new SUMO inhibitor
Pancreatic ductal adenocarcinoma (PDAC) still carries a dismal prognosis with overall five-year survival of 8%. Conventional combination chemotherapies are a clear advance in the treatment of PDAC, however subtypes of the disease exist, which exhibit extensive resistance to such therapies. Genomic M...
ORGANISM(S): Homo sapiens (Human) 
2020-01-06 | PXD011347 | Pride
Pancreatic cancer Myc Sumo Lc-ms/ms 
UnknownDetection and phylogenetic analysis of highly pathogenic A/H5N1 avian influenza clade 2.3.4.4b virus in Chile, 2022.
Not available
S-EPMC10283444 | biostudies-literature
Sort   by:  
 Page size